OBJECTIVE: To identify the incidence of parapharyngeal space (PPS) recurrences and how they impact survival in advanced-stage soft-palate carcinoma patients.
STUDY DESIGN AND SETTING: One hundred thirty-seven patients' charts were reviewed from 1971 to 1996. Inclusion criteria were patients who received a per-oral resection, discontinuous neck dissection, and postoperative adjuvant radiation therapy; 15 patients met criteria for inclusion. The incidence of PPS recurrences, regional failure, and survival were endpoints that were analyzed.
RESULTS: There were no local failures in our study. Regional failures excluding the PPS (levels I-V) were 27%, and 40% occurred within the PPS. Cervical adenopathy was associated with 83% of the PPS recurrences. Median survival for PPS recurrences was 26 months, compared with 67 months for levels I-V recurrences (n = ns).
CONCLUSIONS: The incidence of PPS recurrences is substantial in advanced-stage soft-palate cancer. PPS recurrences negatively impact survival; without effective salvage techniques for these recurrences or effective adjuvant therapy, poor patient outcomes can be expected.
Get full access to this article
View all access options for this article.
References
1.
CantoMTDevesaSS. Oral cavity and pharynx cancer incidence rates in the United States, 1975–1998. Oral Oncol2002; 38: 610–7.
CarrauRLJohnsonJTMyersEN. Management of tumors of the parapharyngeal space. Oncol (Huntington)1997; 11: 633–40.
4.
WeberRSPetersLJWolfPSquamous cell carcinoma of the soft palate, uvula, and anterior faucial pillar. Otolaryngol Head Neck Surg1988; 99: 16–23.
5.
RussJEApplebaumELSissonGA. Squamous cell carcinoma of the soft palate. Laryngoscope1977; 87: 1151–6.
6.
GarrettPGBealeFACummingsBJ. Carcinoma of the oropharynx: Soft palate primary. J Otolaryngol1984; 13: 165–8.
7.
Har-EigShaha AChaudryRCarcinoma of the uvula and midline soft palate: Indication for neck treatment. Head Neck1992; 14: 99–101.
8.
XiaoGLGaoLXuGZ. Prognostic influence of parapharyngeal space involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys2002; 52: 957–63.
9.
NakahiraMNakataniHTakedaT.Syncope as a sign of occult malignant recurrence in the retropharyngeal and parapharyngeal space: CT and MR imaging findings in four cases. AJNR Am J Neuroradiol2002; 23: 1257–60.
10.
ChuaDTShamJSKwongPWLinear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: Efficacy and complications. Int J Radiat Oncol Biol Phys2003; 56: 177–83.
11.
OmuraKShimadaFTakemiyaS.Dissection of parapharyngeal space in head and neck cancer. Auris Nasus Larynx1985; 12Suppl 2: S56–60.
12.
StellPMMansfieldAOStoneyPJ. Surgical approaches to tumors of the parapharyngeal space. Am J Otolaryngol1985; 6: 92–7.
13.
YumotoEOkamuraHYanagiharaN.Transmandibular transpterygoid approach to the nasopharynx, parapharyngeal space, and skull base. Ann Otol Rhinol Laryngol1992; 101: 383–9.
14.
UmedaMYoshikawaTKomoriT.Metastasis of maxillary carcinoma to the parapharyngeal space: Rationale and technique for concomitant en bloc parapharyngeal dissection. Oral Oncol2002; 38: 313–7.
15.
MaloneJPAgrawalASchullerDE. Safety and efficacy of trans-cervical resection of parapharyngeal space neoplasms. Ann Otol Rhinol Laryngol2001; 110: 1093–8.
16.
OlaszLNyaradyZNemethAFailure of alkylating agents to improve induction chemotherapy oropharyngeal squamous cell cancer. Anticancer Res2004; 24: 2557–61.
